114 related articles for article (PubMed ID: 34883001)
21.
Wei X; Liu Z; Zhao Z
Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863
[TBL] [Abstract][Full Text] [Related]
22.
Nazlı H; Gedik G
Pharm Dev Technol; 2021 Sep; 26(7):750-764. PubMed ID: 34154500
[TBL] [Abstract][Full Text] [Related]
23. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
[TBL] [Abstract][Full Text] [Related]
24. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies.
Szota M; Reczyńska-Kolman K; Pamuła E; Michel O; Kulbacka J; Jachimska B
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681827
[TBL] [Abstract][Full Text] [Related]
25. A computational study of PAMAM dendrimer interaction with trans isomer of picoplatin anticancer drug.
Farmanzadeh D; Ghaderi M
J Mol Graph Model; 2018 Mar; 80():1-6. PubMed ID: 29288951
[TBL] [Abstract][Full Text] [Related]
26. Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy.
Marcinkowska M; Stanczyk M; Janaszewska A; Sobierajska E; Chworos A; Klajnert-Maculewicz B
Pharm Res; 2019 Sep; 36(11):154. PubMed ID: 31482205
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug.
Michlewska S; Kubczak M; Maroto-Díaz M; Sanz Del Olmo N; Ortega P; Shcharbin D; Gomez Ramirez R; Javier de la Mata F; Ionov M; Bryszewska M
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31450702
[TBL] [Abstract][Full Text] [Related]
28. New Poly(Propylene Imine) Dendrimer Modified with Acridine and Its Cu(II) Complex: Synthesis, Characterization and Antimicrobial Activity.
Bosch P; Staneva D; Vasileva-Tonkova E; Grozdanov P; Nikolova I; Kukeva R; Stoyanova R; Grabchev I
Materials (Basel); 2019 Sep; 12(18):. PubMed ID: 31540365
[TBL] [Abstract][Full Text] [Related]
29. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
[TBL] [Abstract][Full Text] [Related]
31. Polyamidoamine dendrimers as sweeping agent and stationary phase for rapid and sensitive open-tubular capillary electrophoretic determination of heavy metal ions.
Ge Y; Guo Y; Qin W
Talanta; 2014 Apr; 121():50-5. PubMed ID: 24607109
[TBL] [Abstract][Full Text] [Related]
32. Anionic sulfonated and carboxylated PPI dendrimers with the EDA core: synthesis and characterization of selective metal complexing agents.
García-Gallego S; Cangiotti M; Fiorani L; Fattori A; Muñoz-Fernández MÁ; Gomez R; Ottaviani MF; de la Mata FJ
Dalton Trans; 2013 Apr; 42(16):5874-89. PubMed ID: 23462972
[TBL] [Abstract][Full Text] [Related]
33. Electron capture dissociation and collision-induced dissociation of metal ion (Ag(+), Cu(2+), Zn(2+), Fe(2+), and Fe(3+)) complexes of polyamidoamine (PAMAM) dendrimers.
Kaczorowska MA; Cooper HJ
J Am Soc Mass Spectrom; 2009 Apr; 20(4):674-81. PubMed ID: 19196522
[TBL] [Abstract][Full Text] [Related]
34. Magnetic properties of poly(propylene imine)-copper dendromesogenic complexes: An EPR study.
Domracheva N; Mirea A; Schwoerer M; Torre-Lorente L; Lattermann G
Chemphyschem; 2006 Dec; 7(12):2567-77. PubMed ID: 17089431
[TBL] [Abstract][Full Text] [Related]
35. Re-evaluation of the involvement of NK cells and C-type lectin-like NK receptors in modulation of immune responses by multivalent GlcNAc-terminated oligosaccharides.
Grobárová V; Benson V; Rozbeský D; Novák P; Cerný J
Immunol Lett; 2013; 156(1-2):110-7. PubMed ID: 24076118
[TBL] [Abstract][Full Text] [Related]
36. para-Sulfonatocalix[4]arene and polyamidoamine dendrimer nanocomplexes as delivery vehicles for a novel platinum anticancer agent.
Pang CT; Ammit AJ; Ong YQE; Wheate NJ
J Inorg Biochem; 2017 Nov; 176():1-7. PubMed ID: 28810174
[TBL] [Abstract][Full Text] [Related]
37. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.
Zhang XQ; Intra J; Salem AK
Bioconjug Chem; 2007; 18(6):2068-76. PubMed ID: 17848077
[TBL] [Abstract][Full Text] [Related]
38. Original multivalent copper(II)-conjugated phosphorus dendrimers and corresponding mononuclear copper(II) complexes with antitumoral activities.
El Brahmi N; El Kazzouli S; Mignani SM; Essassi el M; Aubert G; Laurent R; Caminade AM; Bousmina MM; Cresteil T; Majoral JP
Mol Pharm; 2013 Apr; 10(4):1459-64. PubMed ID: 23410260
[TBL] [Abstract][Full Text] [Related]
39. Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer.
Rompicharla SVK; Kumari P; Ghosh B; Biswas S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):847-859. PubMed ID: 29790795
[TBL] [Abstract][Full Text] [Related]
40. EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases.
Klajnert B; Cangiotti M; Calici S; Majoral JP; Caminade AM; Cladera J; Bryszewska M; Ottaviani MF
Macromol Biosci; 2007 Aug; 7(8):1065-74. PubMed ID: 17654761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
